Literature DB >> 18820929

Serum and bronchoalveolar lavage fluid nitric oxide levels in diffuse systemic sclerosis.

Vedat Inal, Kenan Aksu, Gursel Cok, Ferhan Girgin, Gokhan Keser, Fatma Kutay, Eker Doganavsargil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18820929     DOI： 10.1007/s00296-008-0729-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  9 in total

Review 1.  Hypothesis: pathogenesis of systemic sclerosis.

Authors:  Kazuhiko Takehara
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

2.  Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis.

Authors:  T Yamamoto; I Katayama; K Nishioka
Journal:  J Rheumatol       Date:  1998-02       Impact factor: 4.666

3.  Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension.

Authors:  S A Kharitonov; J B Cailes; C M Black; R M du Bois; P J Barnes
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

4.  Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells.

Authors:  Y Allanore; D Borderie; P Hilliquin; A Hernvann; M Levacher; H Lemaréchal; O G Ekindjian; A Kahan
Journal:  Rheumatology (Oxford)       Date:  2001-10       Impact factor: 7.580

5.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

6.  Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis.

Authors:  Paola Failli; Loredana Palmieri; Caterina D'Alfonso; Lisa Giovannelli; Sergio Generini; Angela Del Rosso; Alberto Pignone; Nirvana Stanflin; Stefano Orsi; Lucilla Zilletti; Marco Matucci-Cerinic
Journal:  Nitric Oxide       Date:  2002-12       Impact factor: 4.427

7.  Increased nitric oxide in exhaled air in patients with systemic sclerosis.

Authors:  I Fajac; A Kahan; C J Menkès; J F Dessanges; J Dall'Ava-Santucci; A T Dinh-Xuan
Journal:  Clin Exp Rheumatol       Date:  1998 Sep-Oct       Impact factor: 4.473

8.  Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features.

Authors:  K Takagi; Y Kawaguchi; M Hara; T Sugiura; M Harigai; N Kamatani
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide.

Authors:  K P Tiev; J Cabane; F Aubourg; A Kettaneh; M Ziani; L Mouthon; S Duong-Quy; I Fajac; L Guillevin; A T Dinh-Xuan
Journal:  Eur Respir J       Date:  2007-04-11       Impact factor: 16.671
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.